| Full-length and N-terminally truncated recombinant interleukin-38 variants are similarly inefficient in antagonizing interleukin-36 and interleukin-1 receptors | Cell communication and signaling |  | | 2025 | 112 | 77 |
|
| Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice | Frontiers in immunology | | | 2024 | 148 | 68 |
|
| Oxidation-sensitive cysteines drive IL-38 amyloid formation | Cell reports | | | 2024 | 136 | 59 |
|
| IL ‐38 orchestrates proliferation and differentiation in human keratinocytes | Experimental dermatology | | | 2022 | 279 | 235 |
|
| Epigenetic remodeling of downstream enhancer regions is linked to selective expression of the IL1F10 gene in differentiated human keratinocytes | Gene | | | 2022 | 292 | 209 |
|
| Interleukin-38 interacts with destrin/actin-depolymerizing factor in human keratinocytes | PLOS ONE | | | 2019 | 392 | 241 |
|
| The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression | PLOS ONE | | | 2018 | 522 | 390 |
|
| Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory Responses | Journal of Immunology |  | | 2017 | 770 | 2 |
|
| Severe Neutrophil-Dominated Inflammation and Enhanced Myelopoiesis in IL-33-Overexpressing CMV/IL33 Mice | The Journal of immunology | | | 2015 | 690 | 2 |
|
| Immune-mediated experimental arthritis in IL-33 deficient mice | Cytokine | | | 2014 | 686 | 0 |
|
| Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis | Joint bone spine | | | 2012 | 763 | 919 |
|
| The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters | Journal of leukocyte biology |  | | 2012 | 724 | 0 |
|
| Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice | Annals of the rheumatic diseases | | | 2012 | 690 | 0 |
|
| IL-36R ligands are potent regulators of dendritic and T cells | Blood | | | 2011 | 671 | 0 |
|
| Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis | Arthritis and rheumatism | | | 2009 | 669 | 0 |
|
| Interleukin-33 is biologically active independently of caspase-1 cleavage | The Journal of biological chemistry | | | 2009 | 696 | 573 |
|
| The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33 | Cytokine | | | 2008 | 724 | 0 |
|
| Expression and function of junctional adhesion molecule-C in human and experimental arthritis | Arthritis research & therapy | | | 2007 | 662 | 356 |
|
| Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells | Cytokine | | | 2007 | 535 | 0 |
|
| Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice | Arthritis research & therapy | | | 2004 | 500 | 202 |
|
